Professional Documents
Culture Documents
Preoperative Assessment
Preoperative Assessment
Preoperative Assessment
1. Introduction
2. Goals and Objectives
3. History and examination
4. Airway assessment
5. Medical comorbidities
6. Risk assessment
7. Preoperative testing
8. Preoperative drug management
1. Introduction
1. Mouth opening:
► Beckwith-Wiedemann
syndrome
❖ From the upper border of thyroid cartilage to the tip of jaw with neck
fully extended.
❖ <6 cm is associated with difficult view at laryngoscopy.
❖ Measured with 3 finger breadths.
4.2 Predictors for difficult laryngoscopy
5. Neck movement:
► CAD may range from stable angina to previous myocardial infarction with
evidence of heart failure.
1. MI.
2. Post operative myocardial damage.
3. Increased risk of 30 day post operative mortality.
► Goals:
► Patients with cerebrovascular disease are at risk of further events perioperatively and
in particular may be intolerant of swings in blood pressure.
► Risks appear to be most elevated in the first 3 months, although not surprisingly risk
remains elevated beyond this period and as with CAD, a balance of risks should be
made.
► Preoperative assessment in stroke patients should include:
► Preoperative advices:
❖ 2 days cessation can decreases nicotinic effect, improve mucus clearance
and decrease carboxyhemoglobin levels
❖ 4-8 weeks of cessation are believed to be needed for postoperative
complication reduction
5.2.2 Asthma
► Those who received more than a (burst and taper) of steroids in the previous
6 months should be considered for stress dose perioperatively.
5.2.3 OSA
► COPD patients are vulnerable to have pulmonary hypertension and cor pulmonale
► A full history in COPD patients is essential:
► Patients presenting on the day of surgery with symptoms and signs of a lower
respiratory tract infection should be treated appropriately and postponed to such
time that they are symptom free.
► Viral upper respiratory tract infection can cause bronchial reactivity which may
persist for 3-4 weeks.
► A large thyroid mass may distort the upper airway producing inspiratory
stridor or wheezing, a CXR can show if there is tracheal deviation
► In severe disease, patients may have pericardial effusions, pulmonary fibrosis and
renal impairment.
► Often patients suffer from chronic pain and are on an array of medications which
should ideally be continued in the perioperative period.
American Society of Anesthesiologists
physical status classification
6. Risk assessment
Grade Example
► The most widely used tool for prediction of perioperative cardiac complications is the
Revised Cardiac Risk Index.
► The RCRI uses six preoperative clinical variables that are equally weighted to produce
an estimated risk of cardiac complications:
❖ High risk type of surgery (supra-inguinal vascular, intraperitoneal or intrathoracic
surgery).
❖ History of ischemic heart disease.
❖ History of congestive heart failure.
❖ History of cerebrovascular disease (stroke or TIA).
❖ Insulin therapy for diabetes mellitus.
❖ Preoperative serum creatinine >2.0 mg/dl.
Predicted risk of cardiac complications
using the Revised Cardiac Risk Index (RCRI)
0 0.5
1 1
2 5
3 10
4 15
7. Preoperative testing
► The predictive value of abnormal tests is low in healthy patients with a low
prevalence of disease.
7.1 Preoperative cardiovascular
investigations
► Electrocardiogram:
According to 2014 ACC/AHA guidelines on preoperative evaluation, ECG testing
falls in the following:
❖ Anyone with history of cardiovascular disease such as coronary artery disease,
arrhythmia, peripheral arterial disease, cerebrovascular disease or structural heart
disease.
❖ Not required in patients with no history of coronary artery disease undergoing low
risk surgery.
❖ Consider in asymptomatic patients with no history of coronary artery disease if
undergoing intermediate or high-risk surgery.
► Echocardiogram:
❖ To assess left ventricular function if patients are known to have LV dysfunction and
no echo has been performed within a year.
❖ In patients with known heart failure with increasing dyspnea or a change in their
clinical status.
❖ Reasonable to perform preoperative evaluation of LV function in patients with
dyspnea of unknown cause.
❖ In patients with clinically suspected moderate or greater degrees of valvular stenosis
or regurgitation if there has been either no echo within 1 year or a significant change
in clinical status or physical examination since last echo.
► Exercise tolerance test:
❖ Not indicated for patients with increased risk if they have moderate to
excellent functional capacity (>4-10 METs)
7.2 Other lab testing
► CBC:
❖ A baseline CBC is suggested for all patients 65 years of age or older
❖ When planning neuraxial anesthesia, it is reasonable to measure PLT count
► RBS:
❖ Should be obtained in diabetics.
❖ RBS abnormalities increase with age.
❖ Insulin treated diabetics are at increased risk of postoperative complications.
► Liver function test:
❖ Ordered in liver disease patients
❖ Suspect liver disease from history and examination (jaundice, ascites, itching,
abdominal pain)
► Urine analysis:
❖ Not ordered routinely
❖ If done, to detect UTI, a risk for bacteremia and possible postoperative complications
► Tests for hemostasis:
► COVID-19:
❖ Guidelines suggest screening for exposure or symptoms of coronavirus disease.
❖ Testing is advised in areas of high prevalence.
7.3 Pulmonary function testing
❖ ACP recommends cxr in patients with cardiopulmonary disease and those >50
years old presenting for upper abdominal or thoracic surgeries.
❖ AHA recommends PA, Lateral chest imaging for patients with severe obesity
(undiagnosed HF, chamber enlargement, abnormal pulmonary vasculature
suggestive of pulmonary hypertension).
❖ Not done routinely in smokers unless history suggest pulmonary compromise or
active infection.
7.4 Fasting
Breast milk 4
► Optimal fasting hours decreases volume and acidity of stomach contents and
reduce aspiration and regurgitation risk.
8. Preoperative drug management
❖ For all patients, discontinue all short-acting (e.g., regular) insulin on the day of surgery
(unless insulin is administered by continuous pump).
❖ Patients with type 2 diabetes should take none, or up to one half of their dose of
long-acting or combination (e.g., 70/30 preparations) insulin, on the day of surgery.
❖ Patients with type 1 diabetes should take a small amount (usually one third) of their
usual morning long-acting insulin dose on the day of surgery.
❖ Patients with an insulin pump should continue their basal rate only.
► Non-insulin antidiabetic medications:
If to be stopped, the time interval for discontinuing these medications before surgery is:
► The same applies to patients with bare metal stents until they have completed 1
month of dual antiplatelet therapy.
► Aspirin:
❖ Traditionally, antiplatelet agents were stopped prior to elective surgery due to the
perceived risk of bleeding.